Protocol

NHL16: Study for Newly Diagnosed patients with Acute Lymphoblastic Lymphoma

Diseases

Leukemias / Lymphomas : Acute lymphoblastic leukemia

Description

Lymphomas are cancers that begin in the cells of the immune system. Lymphoblastic lymphoma (LL) is an aggressive (fast-growing) type of non-Hodgkin lymphoma in which too many immature white blood cells, (lymphoblasts) are found in the lymph nodes and the thymus gland. These lymphoblasts may spread quickly to other places in the body. In many ways LL is similar to acute lymphoblastic leukemia (ALL); therefore the treatment for LL is also very similar to treatment used for ALL, and involves many chemotherapy drugs given over several months. The treatments that the patient may receive are called “remission induction, re-intensification, and cranial irradiation or radiation to the brain.

 

Objectives

 

Eligibility

For the current eligibility status of this clinical study, referring physicians must contact St. Jude Children's Research Hospital at 1-866-2ST-JUDE (1-866-278-5833).

Contact

Hiroto Inaba, MD. PhD
St. Jude Children’s Research Hospital
262 Danny Thomas Place
Memphis, TN 38105 USA
Voice: 1-866-2ST-JUDE (1-866-278-5833)
FAX: 901-595-5068

Referring or consulting physicians only: protocolinfo@stjude.org

For all other inquiries about St. Jude Children's Research Hospital studies: info@stjude.org


The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.